Last reviewed · How we verify

NCT05610579

The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related Lymphedema

Completed NA Last updated 1 August 2023
What this trial tests

NA trial testing Remedial exercise in Lymphedema, Breast Cancer in 34 participants. Completed in 28 February 2023.

Timeline
14 November 2022
Primary endpoint
28 February 2023
28 February 2023

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment34
Start date14 November 2022
Primary completion28 February 2023
Estimated completion28 February 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 75, female only, with Lymphedema, Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study to investigate 24 hours of effects of remedial exercises with and without compression therapy on severity of lymphedema and symptoms of the lymphedema The present study is designed as a non-drug clinical trial. The patients will complete two remedial exercise sessions, one without and one with compression in a randomized order separated by a 3-day wash-out period.The main questions it aims to answer are 1. The 24 hour effects of remedial exercises with and without compression therapy on the severity of lymphedema are different in individuals with lymphedema associated with breast cancer surgery. 2. The 24 hour effects of remedial exercises with and without compression therapy on the symptoms of lymphedema are different in individuals with lymphedema associated with breast cancer surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Acute Effects of Remedial Exercises with and without Compression on Breast-Cancer-Related Lymphedema.
    Gülören G, Doğan Y, Özgül S, Gürşen C, et al · · 2023 · cited 4× · PMID 37998441 · DOI 10.3390/healthcare11222949

Verify or expand the search:

Other recruiting trials for Lymphedema, Breast Cancer

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05610579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing